In addition, in this study, XIAP inhibition decreased cell viability and corresponded with MLH1 proteolysis only in MLH1 proficient although p53-mutant ovarian cancer cells and was ineffective in MLH1-deficient cells, revealing a potential p53-independent but MLH1-dependent effect. Here, TP53 is linked to ovarian cancer.